Breast Cancer Community
Metaplastic Carcinoma
About This Community:

This patient support community is for discussions relating to breast cancer, biopsy, genetics, chemotherapy, hormone therapy, lumps, lumpectomy, lymph node dissection, lymphedema, mammograms, mastectomy, radiation therapy, reconstruction, and self exams.

Font Size:
Blank Blank

Metaplastic Carcinoma

I haven't been able to find a lot of information on the particular form of breast cancer that I have.  According to the pathologist, it is metaplastic carcinoma.  I have already had 3 chemotherapy treatments w/cytoxan and doxorubicin and will have the last one this thursday.  Then, repeat all the scans and start w/paclitaxel once a week for 3 wks and off a week for a total of 12 weeks.

I mainly want information on recurrence and survival rates.  I know that it is an aggressive form of breast cancer since the tumor was thought to be walnut sized at the beginning of April and was actually grapefruit sized when it was removed at the end of May.

Any information you can provide will be appreciated.

Related Discussions
I wanted to bring an article to your attention if you don't mind. If I should ever have to go through chemo again, you can count on me doing this for myself before doing any particular chemo, regardless of the cancer type.

Just an FYI :)

"Chemotherapy is such a powerful type of treatment, it is hard to imagine that any type of breast cancer could resist its onslaught. But some breast tumors may resist certain chemotherapy treatments. Rather than prescribe a standard chemotherapy combination without knowing whether or not it would be effective, some oncologists are choosing to test tumor cells in advance of treatment. A chemosensitivity assay can help determine which drugs will most likely shrink the tumor, kill the cancer cells, and give patients the best outcome.

Personalized Treatment for Breast Cancer
Chemotherapy sensitivity and resistance assays (CSRAs) are a relatively new wave of tests done for many types of cancer. A chemosensitivity assay is a laboratory test that is done on a single cell in a test tube (in vitro) or a clump of tumor cells (in vivo), usually taken from a biopsy sample. This test looks at how many cancer cells are killed by a drug, or a combination of drugs, and how many cancer cells resist the treatment. These results are called drug sensitivity and drug resistance.
Once your doctor knows which drugs your cancer will respond to, you can be treated most effectively. This approach ensures that you don't lose any time trying drugs that don't work for you. It also reduces your potential side effects by not subjecting you to powerful toxic drugs that may or may not kill your cancer.

Chemosensitivity Assays Are Not An Escape Hatch
Chemosensitivity testing does not test your potential for side effects from the chemo drugs. The term "chemo sensitive" may sound like this test determines how sick you will feel during treatment. Actually, other factors affect whether or not chemo will cause you some nausea, vomiting, or other side effects. A chemosensitivity assay determines which chemo drugs will make your cancer so 'sick' that it will die.

Testing and Results of a Chemosensitivity Assay
A fresh tissue sample from your tumor will be tested in the lab with several standard single drug doses, and also with standard drug combinations. Your assay report will detail which drugs were used for testing and what doses were used. Each drug will be rated for effectiveness as: sensitive, resistant, intermediate, or active. The lab will make a recommendation for effective treatment, based on the greatest sensitivity score.

Qualifying for A Chemosensitivity Assay
You must meet some qualifications in order for chemosensitivity testing to work for you:
•currently have a solid or fluid tumor site
•be willing to have a new biopsy to get a fresh tissue sample for testing
•have enough strength to undergo chemotherapy
•have access to a lab or facility that does the chemosensitivity assay
Finances and Testing
Not every type of health insurance will cover a chemosensitivity assay. Medicare most likely will not cover this test. You may have to pay out-of-pocket for lab and consultation fees, which may total as much as $800. Depending on your insurance, you may eventually be reimbursed for a portion of the expenses. Consult your insurance provider before proceeding, and make sure you understand the costs and claim procedures.

Chemosensitivity Assay Test is Still Experimental
New medical tests and procedures have to pass rigorous examination and go through clinical trials before they may be eventually adopted as part of standard practice. Chemosensitivity assays are still considered experimental, in development, and concrete results of independent clinical trials are yet to come. As such, this test is not standard, and it will not be offered to every patient until doctors are convinced of its accuracy and value.

Bottom Line on Chemosensitivity Testing
Before starting treatment, you want to be sure that the journey will be worth the travel. What are the chances that you will survive, and how long will you survive? How can you reduce your risk of recurrence? The point of testing your cancer for chemosensitivity and chemo resistance is to make sure you have the best response rate and greatest chance at beating cancer. Research strongly suggests that when patients receive the most effective treatment, matched to their cancer profile, they survive longer.
Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response. Gregory I.S.K. Lau, Wings T.Y. Loo and Louis W.C. Chow. Biomedicine & Pharmacotherapy; Volume 61, Issue 9, October 2007, Pages 562-565.

Ellis RJ, Fabian CJ, Kimler BF et al. Factors associated with success of the extreme drug resistance assay in primary breast cancer specimens. Breast Cancer Res Treat 2002;71(2): 95-102


If you search this forum and also the Breast Cancer Expert Forum for the term "metaplasic carcinoma," you will find a number of previous post and replies on that subject. I have copied one reply at the end of my post; hope it will be of some help.

Warm regards....

by PaulMD, May 09, 2008 05:09AM
Hi there.

Metaplastic carcinoma is indeed an uncommon type of tumor compared to the usual invasive ductal cancers.  If I'm not mistaken, metaplastic carcinoma may behave less invasive and has a more favorable prognosis and course compared to invasive ductal carcinoma.  However, the national comprehensive cancer network (NCCN) has lumped metaplastic with the invasive ductal in terms of treatment:

The consultations that your doctors are doing with each other or with other specialists are very welcome as this would tailor-fit your treatment.  Large specialized centers including Memorial Sloan-Kettering or MD Anderson may have definite protocols for this condition.  Regards.
Thank you so much for the information that you included.  I guess I'm not adept at moving around this site yet.  I just joined and am still trying to figure some things out.

Many thanks.
Welcome to the site and to this community!

Let us know if you need any help finding your way around. (I was a "newbie" myself just a couple of  months ago, and am still learning about some of the site's features.)

I have found, besides the search feature, that the the "Related Discussions" box at the bottom of many threads can be helpful. For example, there are five items  at the bottom of this thread, and when you click on each of them, you may find additional leads in the related discussion boxes below those threads.

And, of course, keep posting any questions you have here, for a wealth of info, sharing of personal experiences, and emotional support, or in the BC Expert Forum if you have a question you would like answereed by a professional.
For additional information, please see Sue Young55's reply to "Metaplastic Breast Cancer," posted  today (9/30/09), by Seacreature.
Continue discussion Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Breast Cancer Community Resources
RSS Expert Activity
Marathon Running Done Over Many Yea...
May 21 by John C Hagan III, MD, FACS, FAAOBlank
New Article on Multifocal IOL vs &q...
May 21 by John C Hagan III, MD, FACS, FAAOBlank
TMJ/TMJ The Connection Between Teet...
01/15 by Hamidreza Nassery , DMD, FICOI, FAGD, FICCMOBlank
Top Breast Cancer Answerers
Lancaster, OH